FDA approves generic Casodex from Sun, Mylan

07/7/2009 | Forbes

Mylan and Sun Pharmaceutical Industries secured FDA clearance for their generic copies of AstraZeneca's prostate cancer drug Casodex. Total U.S. sales of Casodex reached $322 million for the year that ended March 31, said Mylan, which has begun shipping its bicalutamide tablets.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA